SCHEMBL3957356

SCHEMBL3957356

CC(NC(=O)C1c2ccccc2C(=O)N1CCc1ccccn1)c1ccc(OCC(F)(F)F)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 20/20 1.00
KCNH2 Q12809 15/20 1.00
SCN5A Q14524 15/20 1.00
KCNQ2 O43526 1/20 0.60
KCNA5 P22460 1/20 0.60
SCN2A Q99250 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3892332 0.91 SCN9A (0.84) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL13568199 0.86 SCN9A (0.75) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3953595 0.84 SCN9A (1.00) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL13568303 0.80 SCN9A (0.67) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL13568404 0.77 SCN9A (0.62) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL4457611 0.76 SCN9A (1.00) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3954090 0.75 SCN9A (1.00) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL3892334 0.74 SCN9A (0.86) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL4476223 0.74 SCN9A (0.71) SCN9AKCNH2SCN5AKCNQ2KCNA5
SCHEMBL13568403 0.74 SCN9A (1.00) SCN9AKCNH2SCN5AKCNQ2KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009145718-A1 ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO claimed
WO-2009145718-A1 ISOINDOLINE DERIVATIVES COMPRISING AN ADDITIONAL HETEROCYCLIC GROUP AND THEIR USE IN THE TREATMENT OF PAIN DISORDERS ASTRAZENECA AB (SE) 2009-12-03 WO disclosed